How an Alzheimer's 'cabal' thwarted progress toward a cure

This stifling of competing ideas, say a growing number of scholars, is a big reason why there is no treatment for Alzheimer’s.

Related Keywords

Massachusetts ,United States ,Germany ,University Of Southern California ,California ,Taiwan ,San Francisco ,German ,Daniel Alkon ,Inmune Bio ,Susan Fitzpatrick ,George Perry ,Nikolaos Robakis ,Eli Lilly ,Dennis Selkoe ,Auguste Deter ,Ruth Itzhaki ,Davangere Devanand ,Alois Alzheimer ,Rachael Neve ,Paul Aisen ,Athena Neurosciences ,Neurotrope Bioscience ,University Of Texas At San Antonio ,Alzheimer Association International Conference ,Emory University ,Novartis ,England University Of Manchester ,Pfizer ,Jamess Mcdonnell Foundation ,University Of Texas ,Alzheimer Association ,College Of Sciences ,National Institute Of Neurological Disorders ,Harvard Medical School ,Columbia University ,Ruth Itzhaki Courtesy University Of Manchester ,Icahn School Of Medicine At Mount Sinai ,Mcdonnell Foundation Fitzpatrick ,Massachusetts General ,National Institute ,Neurological Disorders ,Southern California ,Aspen Ideas Festival ,Courtesy University ,Medical Virology ,Zenith Fellowships ,San Antonio ,Association International Conference ,Mount Sinai ,Icahn School ,Mcdonnell Foundation ,Raymond Tesi ,Jack De La Torre ,